Opportunities for novel therapeutic agents acting at chemokine receptors

Citation
J. Saunders et Cm. Tarby, Opportunities for novel therapeutic agents acting at chemokine receptors, DRUG DISC T, 4(2), 1999, pp. 80-92
Citations number
106
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DISCOVERY TODAY
ISSN journal
13596446 → ACNP
Volume
4
Issue
2
Year of publication
1999
Pages
80 - 92
Database
ISI
SICI code
1359-6446(199902)4:2<80:OFNTAA>2.0.ZU;2-I
Abstract
Chemokines are proinflammatory mediators that primarily control leukocyte m igration into selected tissues and upregulation of adhesion:receptors. They also have a role in pathological conditions that require neovascularizatio n and are implicated in the suppression of viral replication. By interactio n with their respective G-protein-coupled receptor, chemokines have a profo und influence cover the selective recruitment of specific cell types in acu te inflammatory disease and, hence, inhibition of their action should be Of therapeutic benefit. Only now are small molecule inhibitors becoming avail able tb validate this speculation. In this review without seeking to be com prehensive, the authors provide an introduction to chemokines, their recept ors and their role in certain disease processes, Also, recent disclosures c laiming novel nonpeptide ligands for chemokine receptors are summarized.